Authors
Loading...
In silico approach reveals new BACE1 inhibitors with enhanced binding affinity, suggesting potential for AD treatment.
Hazazi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: